Unknown

Dataset Information

The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors.


ABSTRACT:

Background

Warfarin is a drug with a narrow therapeutic index and large interindividual variability in daily dosing requirements. Patients commencing warfarin treatment are at risk of bleeding due to excessive anticoagulation caused by overdosing. The interindividual variability in dose requirements is influenced by a number of factors, including polymorphisms in genes mediating warfarin pharmacology, co-medication, age, sex, body size and diet.

Aims

To develop population pharmacokinetic models of both R- and S-warfarin using clinical and genetic factors and to identify the covariates which influence the interindividual variability in the pharmacokinetic parameters of clearance and volume of distribution in patients on long-term warfarin therapy.

Methods

Patients comm

SUBMITTER: Lane S 

PROVIDER: S-EPMC3248257 | biostudies-literature | 2012 Jan

REPOSITORIES: biostudies-literature